JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences
JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger of